Emergent BioSolutions
EBS
#8033
Rank
โ‚น35.53 B
Marketcap
โ‚น688.72
Share price
-0.55%
Change (1 day)
40.26%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -โ‚น14.78

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -โ‚น16.22. In 2025 the company made an earnings per share (EPS) of โ‚น90.62 an increase over its 2024 EPS that were of -โ‚น346.27.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น14.78-116.31%
2025โ‚น90.62-126.17%
2024-โ‚น346.27-75.61%
2023-โ‚น1,420232.21%
2022-โ‚น427.35-203.46%
2021โ‚น413.04-25.09%
2020โ‚น551.35445.28%
2019โ‚น101.11-15.2%
2018โ‚น119.24-35.9%
2017โ‚น186.0169.57%
2016โ‚น109.70-27.67%
2015โ‚น151.6765.62%
2014โ‚น91.5711.63%
2013โ‚น82.0432.31%
2012โ‚น62.00

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.96-870.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น341.01-2,202.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น370.72-2,386.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚น252.78 1,458.82%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
โ‚น33.39-305.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น406.36 2,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น130.68-905.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel